October 24th 2024
How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
October 18th 2024
A panel dives into the current and future outlook of healthcare policies.
October 16th 2024
The session dives into the obstacles surrounding data usability, mandate compliance, initial adoption, and limitations in this arena.
October 15th 2024
The conference’s opening keynote sets the scene for 2025 and the years to come.
September 30th 2024
Why this trend is occurring and ways that drugmakers are pivoting in order to remedy the situation.
Practice Fusion EHR and OPTIMIZERx team up to expand sample, coupon access
Compliance issues around sampling will be featured at upcoming conference
The Context Renaissance in Pharma
The next generation of MDM
The maturing rare-disease market
As rare diseases have emerged as a market opportunity for pharma over the past several years, industry practices are beginning to stabilize
EvaluatePharma forecast: 2020 global pharma sales of $1.107 trillion
After patent expires, 'The industry has turned a corner'
Agency rides the rare-disease wave
Siren Interactive hires more executives, moves to downtown Chicago
Pharma brand teams need to reset their patient-journey analysis, says IMS Consulting
Real-world data sources can provide new dimensions to marketing plans
Pharma rep access: down, down, down
Latest ZS AccessMonitor asks, 'Who are physicians listening to?'
Specialty pharmaceuticals demand integrated patient and prescriber approaches
True 'market access' should involve coordinated approaches to patients and their healthcare providers
Sovaldi, the $1,000 pill
The eye-popping price tag on the hepatitis C drug, from Gilead Sciences, has prompted unprecedented pushback from payers
Veeva expands physician-contact tools with Engage, a multichannel communications link
Company also announces a 10-year agreement with Salesforce.com
McKesson and Physicians Interactive expand their e-coupon partnership
Service connects McKesson industry clients to PI's network of e-prescribing and EHRs
Clinical pathways under Medicare?
Bending the cost curve in oncology
A rising flow of new, expensive therapies is transforming relationships among payers and providers. Manufacturers will have to react nimbly to the changes
IMS Institute assesses social media for industry significance
J&J is the far-and-away leader in the IMS Health Social Media Engagement Index
Getting from multichannel marketing to customer-centric marketing
Today's pharma marketers have the tools to refine their communication efforts to prescribers and patients
Buzzwords pharma marketers should know
Not just 'social listening' but social understanding
How new social health analytics tools are supercharging pharma's quest for patient insight
QPharma offers QLaunch advisory service
Formulary exclusion—the ultimate revenge?
Promotional experimentation and consumer outreach will be available via the Truvio network
New service launched by WEGO Health offers rapid feedback from key opinion influencers in consumer healthcare
Annual Cegedim survey finds emphasis on changing commercial models
Multichannel marketing is high in attention, but low on execution; Docnet will be a new social media platform
Copay programs' increased value to manufacturers is matched by rising criticism
Despite proven medical value, coupon and copay offset programs continue to draw fire from insurers; meanwhile, will the programs extend to ACA insureds?
CVS Caremark opens a $67-million, 400-employee mail-order pharmacy in Illinois
Highly automated facility can process 50 million prescriptions annually for CVS Caremark's book of business
Prime Therapeutics sets the parameters of specialty-drug purchasing discussions
Blue Cross/Blue Shield PBM says seven steps help manage costs
CSOs broaden their palette of service offerings
While riding the same downturn as overall pharma sales-rep headcount, contract sales organizations (CSOs) have invested in IT competency and marketing services to meet client needs
Social media's other challenges
Biomarkers and companion diagnostics expand drug potential
Essential for approving some new products, biomarkers are becoming integrated with patient therapies
Covance builds out its managed-markets advisory service
Company will provide services to manage data and terms of sales contracts
At ASCO meeting, McKesson showcases US Oncology capabilities
Demonstration of second-generation IKnowMed EHR; over 90 studies involve US Oncology Network researchers